Overview

Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

Observe the therapeutic efficacy of human menopausal gonadotropin combining with human chorionic gonadotropin in adolescent boys with congenital hypogonadotropic hypogonadism.

Phase:

Phase 4

Details

Lead Sponsor:

Beijing Children's Hospital

Treatments:

Chorionic Gonadotropin
Menotropins